Literature DB >> 32898646

Striatal circuit development and its alterations in Huntington's disease.

Margaux Lebouc1, Quentin Richard1, Maurice Garret2, Jérôme Baufreton3.   

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder that usually starts during midlife with progressive alterations of motor and cognitive functions. The disease is caused by a CAG repeat expansion within the huntingtin gene leading to severe striatal neurodegeneration. Recent studies conducted on pre-HD children highlight early striatal developmental alterations starting as soon as 6 years old, the earliest age assessed. These findings, in line with data from mouse models of HD, raise the questions of when during development do the first disease-related striatal alterations emerge and whether they contribute to the later appearance of the neurodegenerative features of the disease. In this review we will describe the different stages of striatal network development and then discuss recent evidence for its alterations in rodent models of the disease. We argue that a better understanding of the striatum's development should help in assessing aberrant neurodevelopmental processes linked to the HD mutation.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Basal ganglia; Huntington's disease; Matrix; Medium spiny neurons; Neuronal excitability; Spiny projection neurons; Striatal development; Striosomes

Year:  2020        PMID: 32898646     DOI: 10.1016/j.nbd.2020.105076

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

Review 1.  From Progenitors to Progeny: Shaping Striatal Circuit Development and Function.

Authors:  Rhys Knowles; Nathalie Dehorter; Tommas Ellender
Journal:  J Neurosci       Date:  2021-11-17       Impact factor: 6.167

2.  Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-07-20       Impact factor: 4.632

3.  Novel Substituted Benzothiazole Compounds for Treating Huntington's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-03-31       Impact factor: 4.345

4.  Novel Substituted Monocyclic Heteroaryl Compounds for Treating Huntington's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2020-12-10       Impact factor: 4.345

Review 5.  Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.

Authors:  Ewelina Latoszek; Magdalena Czeredys
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 6.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

7.  Transcription factor Sp9 is a negative regulator of D1-type MSN development.

Authors:  Zhenmeiyu Li; Zicong Shang; Mengge Sun; Xin Jiang; Yu Tian; Lin Yang; Ziwu Wang; Zihao Su; Guoping Liu; Xiaosu Li; Yan You; Zhengang Yang; Zhejun Xu; Zhuangzhi Zhang
Journal:  Cell Death Discov       Date:  2022-06-30

Review 8.  Gene targeting techniques for Huntington's disease.

Authors:  Eric Fields; Erik Vaughan; Deepika Tripu; Isabelle Lim; Katherine Shrout; Jessica Conway; Nicole Salib; Yubin Lee; Akash Dhamsania; Michael Jacobsen; Ashley Woo; Huijing Xue; Kan Cao
Journal:  Ageing Res Rev       Date:  2021-06-05       Impact factor: 11.788

Review 9.  Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.

Authors:  Poornima D E Weerasinghe-Mudiyanselage; Mary Jasmin Ang; Sohi Kang; Joong-Sun Kim; Changjong Moon
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

10.  An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptoms.

Authors:  Lila Lovergne; Dhruba Ghosh; Renaud Schuck; Aris A Polyzos; Andrew D Chen; Michael C Martin; Edward S Barnard; James B Brown; Cynthia T McMurray
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.